Robert W Baird Upgrades MDAS To Outperform

Lisa Levin , Benzinga Staff Writer

November 23, 2010 7:01am Comments

Analysts at Robert W Baird upgrade MedAssets Inc (NASDAQ: MDAS) from "neutral" to "outperform." The target price for MDAS has been raised from $21 to $25.

MDAS' shares gained 0.34% to close at $16.77 yesterday.

More Analyst Ratings here

View Comments and Join the Discussion!

View the discussion thread.

Posted-In: Robert W Baird Upgrades Price Target Analyst Ratings

Need analyst data?
Click here to see licensing options.

Latest Ratings

Stock	Firm	Action	PT
SEDG	B of A Securities	Maintains	411.0
PTLO	Piper Sandler	Maintains	28.0
AOUT	Lake Street	Maintains	26.0
RAPT	Piper Sandler	Maintains	52.0
OCX	Lake Street	Maintains	6.0

View the Latest Analytics Ratings

1	VOO, TSLA: US Stocks Hit New Highs As Magnificent Seven Reach $19 Trillion: What&#...
2	$BTC, $SOL: Anthony Scaramucci May Not Have Seen Eye-To-Eye With Trump On...
3	$BTC, $ETH: Bitcoin Could See Bearish August, Analyst Says—Wh...
4	LMT, BAH: Trump's $151 Billion 'Golden Dome...
5	TSLA, GOOGL: Dow Dips Over 300 Points Amid Al...
6	HIMS, PHM: Benzinga's 'S...
7	CHTR: Charter Communicati...

1	Gen X Is Nearing Retirement With Empty Wallets And A New Nickname — 'Silv...
2	31-Year-Old Couple Making $210K Has Only $100 Left to Spend Each Week — Now Th...
3	The Rich And Profitable Corporations Get Tax Cuts But 22 Million Families Lose N...
4	$BTC: Scams, Lost Keys, and Forgotten Wallets: The Bitcoin Whisperer Who Brings Cr...
5	Exiled Iranian Prince Reza Pahlavi Claims 50,000 Defectors Have Joined His M...
6	META: Mark Zuckerberg's Meta Platforms Dodges $8 Billion Trial With Eleve...
7	'She Just Does What She Wants With It': Disabled Man Says Mom...

Market Overview

Tickers

Articles

Keywords

Robert W Baird Upgrades MDAS To Outperform

Related Articles (MDAS)

Latest Ratings